Trademarkia Logo

Canada

C$
SUREXAM
REGISTERED

on 18 Mar 2010

Last Applicant/ Owned by

SUREXAM BIO-TECH CO. LTD.

No. 29, Helix 3rd Road, International Biological IslandHuangpu DistrictGuangdong ProvinceGuangzhou City,

CN

Serial Number

1380210 filed on 22nd Jan 2008

Registration Number

TMA761968 registered on 18th Mar 2010

Registration expiry Date

18th Mar 2035

Correspondent Address

NEOMARK LTD.

7450 rue Saint-HubertMontréal

QUEBEC

CA

H2R2N3

SUREXAM

Trademark usage description

pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceut Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of carpal tunnel syndrome; Pharmaceutical preparations for the treatment of dental and oral diseases; Pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations for the treatment of headaches; Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; Pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; Pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; Pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, schizophrenia; Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; Pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; Pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; Pharmaceutical preparations for the treatment of the respiratory system; Pharmaceutical preparations for the treatment of varicose veins; Pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); Pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; Pharmaceutical preparations for use in gastroenterology; Pharmaceutical preparations for use in ocular disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in ophthalmology; Drugs for medical purposes, namely analgesics, antibiotics, anti-inflammatory agents, cardiovascular agents, hormones for humans; concentrated elixirs in liquid form for oral consumption containing vitamins, minerals, Herbal supplements for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, and Herbal supplements for the treatment of headaches; Pharmaceuticals and drugs for medical purposes, namely, analgesics, anesthetics, antacids, antibiotics, antihistamines, cathartics, depressants, expectorants, hormones for humans, and stimulants; Biochemical pharmaceuticals, namely chorionic gonadotrophin, erythropoietin, heparin calcium, heparin sodium, human menopausal gonadotrophin, kallikrein, pancreatin, pig thyroid gland, rabbit brain powder; Blood products and preparations for veterinary purposes, including therapeutic blood products and blood plasma, namely horse plasma preparations including hyperimmune plasma; Diagnostic preparations for clinical or medical laboratory use; Biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones for humans, and enzymes for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; Veterinary preparations, namely biological preparations for veterinary purposes, cultures of microorganisms for veterinary use, chemical preparations for veterinary use, chemical reagents for veterinary purposes; Insecticides.


Classification kind code

12

Mark Details


Serial Number

1380210

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 22nd May 2009
Allowed
Submitted for opposition 51
on 22nd May 2009
Allowance Notice Sent
Submitted for opposition 42
on 4th Feb 2009
Advertised
Submitted for opposition 26
on 29th Jan 2009
Approved
Submitted for opposition 27
on 9th Dec 2008
Approval Notice Sent
Submitted for opposition 22
on 25th Aug 2008
Search Recorded
Submitted for opposition 20
on 25th Aug 2008
Examiner's First Report
Submitted for opposition 31
on 24th Jan 2008
Formalized
Submitted for opposition 1
on 23rd Jan 2008
Created
Submitted for opposition 30
on 22nd Jan 2008
Filed